| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/26/2013 | CN102241736B Method for synthesizing key intermediate of antitumour medicament Romidepsi |
| 06/25/2013 | US8470782 Transglutaminase inhibitors and methods of use thereof |
| 06/25/2013 | US8470781 Use of effectors of glutaminyl and glutamate cyclases |
| 06/20/2013 | WO2013087743A1 Inhibitors of hcv ns5a |
| 06/20/2013 | WO2013073968A3 Agents for modulation of cell signalling |
| 06/20/2013 | US20130157946 Neurotrophic peptides |
| 06/20/2013 | US20130156819 Isolation of mesenchymal stem cells |
| 06/20/2013 | CA2855574A1 Inhibitors of hcv ns5a |
| 06/19/2013 | EP2604621A1 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604287A2 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604286A1 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | EP2604285A1 Method and Carrier Complexes for Delivering Molecules to Cells |
| 06/19/2013 | CN103168029A Salts and polymorphs of sulfamide ns3 inhibitors |
| 06/19/2013 | CN103159828A 1-(4-hydroxy-3-methoxycarbonyl)-beta-carboline-3-formyl tryptophyl amino acid benzyl ester, and synthesis and application thereof |
| 06/19/2013 | CN103159827A Synthesis, anti-thrombotic activity, and application of (1R, 3S) -1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid |
| 06/19/2013 | CN103159826A Lys and Lys (Pro-Ala-Lys)-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159819A Synthesis of cholesterol derivative and application thereof in gene transfection |
| 06/19/2013 | CN102250127B Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof |
| 06/19/2013 | CN102241675B (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof |
| 06/19/2013 | CN101914134B Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein |
| 06/18/2013 | US8465746 Compositions and methods for treatment, research and therapeutic applications for malaria |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/13/2013 | US20130150309 Cyclized peptidomimetic small molecule inhibitors of the wdr5 and mll1 interaction |
| 06/13/2013 | US20130150290 Crystalline Peptide Epoxy Ketone Protease Inhibitors and the Synthesis of Amino Acid Keto-Epoxides |
| 06/13/2013 | US20130150289 Crystalline Peptide Epoxy Ketone Protease Inhibitors and the Synthesis of Amino Acid Keto-Epoxides |
| 06/13/2013 | US20130150283 Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species |
| 06/13/2013 | US20130149372 Polypeptides for the Treatment or Prevention of Cancer and uses Thereof |
| 06/13/2013 | US20130149240 99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS |
| 06/12/2013 | EP2601287A1 Dipeptides to enhance yield and viability from cell cultures |
| 06/12/2013 | CN103153329A Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| 06/12/2013 | CN103145796A Synthesis process of neotame |
| 06/12/2013 | CN103145616A Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 06/12/2013 | CN103145608A Anti-enterovirus 71 (EV71) caprolactam compounds, and preparation method and application thereof |
| 06/12/2013 | CN102190706B Loach protein antihypertensive peptide and preparation method thereof |
| 06/11/2013 | US8461313 Conjugates and compositions for cellular delivery |
| 06/11/2013 | US8461298 Compositions and methods for modification of biomolecules |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/11/2013 | CA2400410C Antimicrobial compounds and formulations |
| 06/11/2013 | CA2312826C Hemiasterlin analogs |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/06/2013 | WO2013082045A1 Netrin loop peptide mimetics and uses thereof |
| 06/06/2013 | WO2013082017A1 Cyclized peptidomimetic small molecule inhibitors of the wdr5 and mll1 interaction |
| 06/06/2013 | WO2013081091A1 Drug for producing radiolabeled polypeptide reducing non-specific renal accumulation |
| 06/06/2013 | US20130144037 Novel lipid peptide and hydrogel |
| 06/06/2013 | US20130144036 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 06/06/2013 | US20130143976 Medical device with predefined activated cellular integration |
| 06/06/2013 | US20130143826 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 06/06/2013 | US20130143809 Neurotrophic peptides |
| 06/06/2013 | US20130142764 Methods and compositions for treating brain diseases |
| 06/06/2013 | US20130142754 Hepatitis C Virus Inhibitors |
| 06/05/2013 | EP2598517A1 Modulators of protease activated receptors |
| 06/05/2013 | CN103130871A Preparation method and application of prodrug of endopeptidase activated doxorubicin |
| 06/05/2013 | CN103130870A Preparation method of alpha-L-aspartate-L-phenylalanine methyl ester hydrochloride |
| 06/05/2013 | CN103130869A Antihypertensive peptides prepared by ultrasonic-assisted flour weevil larva proteolysis and preparation method thereof |
| 06/05/2013 | CN102321153B Preparation method of xin'ao glycoside peptide powdery solid |
| 06/05/2013 | CN102250204B RGD sequence peptidyl methyl curcumin compounds, preparation method thereof, and application thereof |
| 06/05/2013 | CN101883781B 7P peptide and its derivant, the use thereof |
| 06/05/2013 | CN101768208B Novel 18F-labelled polypeptide, preparation method and application thereof in tumor imaging |
| 06/04/2013 | US8455624 Methods and compositions for detecting endometrial or ovarian cancer |
| 06/04/2013 | US8455447 Modified therapeutic agents |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 05/30/2013 | WO2013075630A1 Nano particles of nucleic acid and preparation process and use thereof, and three-head single chain nucleic acid unit |
| 05/30/2013 | US20130137852 Novel compounds as dpp-iv inhibitors and process for preparation thereof |
| 05/30/2013 | US20130137637 Peptides for promoting angiogenesis and an use thereof |
| 05/30/2013 | US20130137139 Processes for preparing tubulysins |
| 05/29/2013 | EP2596008A1 Tubulysin analogues |
| 05/29/2013 | CN103121959A Compound, nucleic acid compound molecules and nucleic acid complex as well as preparation methods and application thereof |
| 05/29/2013 | CN101878019B Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k |
| 05/28/2013 | US8450456 Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it |
| 05/28/2013 | US8450454 Compositions for inhibiting ABAD/ABeta protein interaction |
| 05/28/2013 | US8450271 Peptide-based scaffolds for cartilage regeneration and methods for their use |
| 05/28/2013 | CA2644552C Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/23/2013 | WO2013072526A1 Selective imaging of actin in live native cells |
| 05/23/2013 | WO2013071715A1 Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments |
| 05/23/2013 | US20130131338 Substituted diketopiperazines as oxytocin antagonists |
| 05/23/2013 | US20130131311 Aziridine mediated native chemical ligation |
| 05/23/2013 | US20130130992 Dipeptide derivative for the treatment of cancer |
| 05/23/2013 | US20130130980 Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by Intraceptors |
| 05/23/2013 | US20130130968 Compounds for enzyme inhibition |
| 05/23/2013 | US20130130268 Epitopes of the human pdgf receptor able to bind human auto-antibodies, antibodies and uses thereof |
| 05/23/2013 | US20130129753 Cytotoxic peptides and antibody drug conjugates thereof |
| 05/23/2013 | US20130129689 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/23/2013 | US20130129671 Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus |
| 05/23/2013 | US20130129621 Integrin Receptor Antagonists and Their Methods of Use |
| 05/23/2013 | CA2852860A1 Cytotoxic peptides and antibody drug conjugates thereof |
| 05/22/2013 | EP2594290A1 Selective imaging of actin in live native cells |
| 05/22/2013 | EP2593471A1 Cyclotetrapeptides with pro-angiogenic properties |
| 05/22/2013 | EP2593123A1 Romidepsin solid forms and uses thereof |
| 05/22/2013 | CN101506223B 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 05/21/2013 | US8445634 Method of producing FR901228 |
| 05/21/2013 | US8445440 Dimeric IAP inhibitors |
| 05/21/2013 | US8445006 Biomolecular coating for implants |
| 05/21/2013 | CA2594411C Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 05/16/2013 | US20130123485 Cationic lipids, methods for preparing the same, and delivery systems having ability to transition into cells comprising the same |
| 05/16/2013 | US20130123465 Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
| 05/16/2013 | US20130123187 Peptides for the regulation of neurotransmitter sequestration and release |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130123140 Identification of compounds modifying a cellular response |